FindTrial
Sign In

Routine Minimally Invasive Thoracic Surgery Without Aspirin Withdraw

Routine Minimally Invasive Thoracic Surgery Without Aspirin Withdraw Before Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05511441
Enrollment
60
Registered
2022-08-23
Start date
2020-06-01
Completion date
2025-06-01
Last updated
2022-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aspirin Sensitivity, Surgery

Keywords

Aspirin, Minimally Invasive Thoracic Surgery, Safety

Brief summary

Surgeons are increasingly confronted by patients on long-term low-dose acetylsalicylic acid (ASA). However, the perioperative management of these patients undergo non-cardiac surgery has not yet been clear. This single- arm study was to evaluate the safety of continuous use of ASA in the perioperative period in routine minimally thoracic surgery.

Interventions

PROCEDURESurgery Without Aspirin Withdraw

Routine Minimally Invasive Thoracic Surgery Without Aspirin Withdraw

Sponsors

The Second Hospital of Shandong University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. patients with stage I-IIIa Non-small-cell Lung Cancer underwent radical resection or other benign lung lesions need Minimally Invasive Thoracic Surgery; 2. VATS and robotic surgery are both permitted; 3. cardio-pulmonary function can tolerate surgery.

Exclusion criteria

1. cardio-pulmonary function couldn't tolerate surgery; 2. high bleeding risk after the pre- operative evaluation.

Design outcomes

Primary

MeasureTime frameDescription
postoperative complication ratewithin 14 days after surgerypostoperative complication rate
surgery timeon the surgery daytotal surgery time
postoperative drainage volumewithin 7 days after surgerychest drainage volume after surgery
postoperative hospitalization timewithin 7 days after surgerypostoperative hospitalization time
postoperative drainage durationwithin 7 days after surgerychest drainage duration after surgery
bleeding volumeon the surgery daybleeding volume during surgery

Secondary

MeasureTime frameDescription
overall survivalwithin 10 years after surgeryoverall survival
progression- free survivalwithin 5 years after surgeryprogression- free survival

Countries

China

Contacts

Primary ContactYunpeng Zhao
zyp_baggio@163.com18766188692

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026